Home › Funds › Velan Capital Investment Management LP › XLO

Velan Capital Investment Management LP position in XLO

XILIO THERAPEUTICS INC · Health Care

Velan Capital Investment Management LP reported holding 14,285 shares of XLO (XILIO THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$137K, representing 0.09% of its reported portfolio and ranking #44 among its reported holdings. Velan Capital Investment Management LP has disclosed XLO holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)14.29K sh
Reported value held$136.85K
Portfolio Weight0.09%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Velan Capital Investment Management LP's XLO position evolved

Velan Capital Investment Management LP first disclosed a stake in XLO in Q4 2025 at 170,000 shares (US$109K). The position peaked in Q2 2026 at 14,285 shares, worth US$137K. Across 3 filings, Velan Capital Investment Management LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 14,285 shares valued at US$137K. Notable position changes include a 92% trim in Q1 2026 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 170.00K $108.83K New
Q1 2026 14.29K $120.14K Reduce
Q2 2026 14.29K $136.85K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XLO and 13F data

XLO (XILIO THERAPEUTICS INC) is a Health Care company. 24 other funds we track also report a position in XLO — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$6.4M), GILEAD SCIENCES, INC. (US$6.2M), Frazier Life Sciences Management, L.P. (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XLO

All XLO fund holders →

FAQ

How long has Velan Capital Investment Management LP held XLO?

Velan Capital Investment Management LP has disclosed XLO holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Velan Capital Investment Management LP's current position in XLO?

As of Q2 2026, Velan Capital Investment Management LP holds 14.29K shares of XLO (XILIO THERAPEUTICS INC), valued at $136.85K, representing 0.09% of its reported portfolio and ranking #44.

Has Velan Capital Investment Management LP been buying or selling XLO?

In the latest 13F filing (Q2 2026), Velan Capital Investment Management LP held unchanged its position in XLO. The position peaked in Q2 2026 at 14.29K shares.

Which other funds hold XLO?

Other major institutional holders of XLO include Bain Capital Life Sciences Investors, LLC, GILEAD SCIENCES, INC., Frazier Life Sciences Management, L.P., among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.